Speakers

Current strategies for CLTI: Decision-making in below-the-knee revascularisation

vega de céniga

Melina VEGA DE CÉNIGA | Evidence-based management of CLTI: Guidelines, trials and gaps

Dr. Melina Vega de Céniga is a vascular and endovascular surgeon based in Spain and a recognized expert in aortic disease, carotid disease, and peripheral arterial disease. She serves as Head of the Vascular Surgery Unit at Hospital de Galdakao-Usansolo (Bilbao) and has played an active leadership role within the Spanish Society of Vascular Surgery (SEACV). Dr. Vega de Céniga combines a busy clinical practice with a strong academic profile, having authored numerous scientific publications and contributed extensively to vascular research and education. She is a frequent speaker at international vascular meetings and is widely respected for her work in advancing evidence-based vascular care.
Lieven Maene

Lieven MAENE | Endovascular first strategy in BTK disease: Evidence vs reality

Dr. Lieven Maene is a vascular and thoracic surgeon at AZORG (formerly OLV Hospital) Aalst, Belgium, where he has been practicing since 2008. After completing his medical training at Ghent University and advanced training in vascular and thoracic surgery at several leading national and international centres, he developed a particular expertise in endovascular therapies and below-the-knee revascularisation. Dr. Maene has a special interest in vascular disease in diabetic and renal patients, with a strong focus on limb salvage and innovative treatment strategies. Actively involved in clinical research, international multicentre studies, and medical innovation, he regularly presents his work at leading vascular congresses and contributes to the development of new healthcare technologies.
Rachael-Forsythe

Rachael FORSYTHE | Open vs. endovascular BTK revascularisation: When bypass still matters

Dr. Rachael O. Forsythe, MBChB, PhD, FRCS (Vasc) is a Consultant Vascular Surgeon at the Edinburgh Vascular Unit, Royal Infirmary of Edinburgh, an Honorary Research Fellow at the University of Edinburgh and NHS National Research Scotland Clinician.  She combines a busy clinical practice with a strong academic and educational portfolio, with a particular interest in using imaging biomarkers to better predict outcomes in vascular disease. Dr. Forsythe has led and contributed to pioneering molecular and cellular imaging research on abdominal aortic aneurysms, peripheral artery disease and carotid artery disease, serves as an Editor of BMJ Surgery, Associate Editor of BJS Open and Editor of Journal of Vascular Surgery: Vascular Insights, and is a frequent invited speaker at major international vascular meetings. She is widely respected for her contributions to vascular research, education, and international collaboration. She is also Chair of the Circulation Foundation – the UK’s vascular charity – and a member of the Executive Committee of the Vascular Society of Great Britain and Ireland.

Lijckle van der Laan

Lijckle VAN DER LAAN | Conservative management as first choice in CLTI patients?

Prof. Dr. Lijckle van der Laan is a vascular surgeon and Program Director of Vascular Surgery and the Frail Patient at Amphia Hospital in Breda, the Netherlands. He also serves as Visiting Professor at UZ Leuven and holds a position as Endowed Professor of Value-Based Health Care at TIAS School for Business and Society and Tilburg University.
With a longstanding interest in peripheral arterial disease, aortic surgery, frailty, quality of life, and shared decision-making, he has been a pioneer in research on appropriate care for elderly vascular patients. Prof. van der Laan, along with his fellow vascular surgeons, is a pioneer in implementing the “do no further harm” principle, in other words, conservative treatment. His vascular department is recognized as top clinic centre of expertise in the STZ care register for vascular surgery and the frail patient. 

Durability of below-the-knee revascularisation: Restenosis, patency and failure

Konstantinos-Stavroulakis

Konstantinos STAVROULAKIS | Restenosis after BTK endovascular therapy: Repeat, escalate or change strategy?

Dr. Konstantinos Stavroulakis is Associate Professor of Vascular Surgery and Head of the Peripheral Arterial Disease (PAD) Program at Ludwig Maximilian University (LMU) Munich. After graduating from the University of Crete, he completed his vascular and endovascular surgery training in Münster, Germany, where he subsequently held consultant positions before joining LMU Munich in 2021. Dr Stavroulakis is internationally recognized for his expertise in peripheral arterial disease, endovascular therapies, and limb salvage. He serves on the PAD Committee of the German Society for Vascular Surgery and the Revascularization Committee of the CLI Global Society, and is co-founder of Vascupedia, a leading educational platform for vascular specialists.
alessandro ucci

Alessandro UCCI | Infrainguinal bypass patency in CLTI: Determinants of success and failure 

Dr. Alessandro Ucci is a vascular surgeon with a special interest in chronic limb-threatening ischaemia (CLTI), diabetic foot disease, and advanced endovascular revascularisation techniques. After graduating from the University of Pavia and completing his vascular surgery training at the University of Bologna, he worked at the University Hospital of Parma and the renowned Diabetic Foot Center of Clinica San Carlo, where he collaborates closely with Dr. Roberto Ferraresi. Dr. Ucci has developed particular expertise in the management of complex “no-option” CLTI patients, including foot vein arterialization and other limb salvage strategies. He is an active researcher, author of numerous scientific publications, and a frequent speaker at international vascular meetings.
58535_fullimage_cid52954_1660733850848_8482_fullimage_mf005782 mark koelemaij_512x512

Mark KOELEMAY | When revascularisation fails in CLTI: Clinical and economic decision-making 

Dr. Mark J.W. Koelemay is a vascular surgeon and clinical epidemiologist at Amsterdam UMC, where he has been working since 2007. A specialist in vascular surgery since 2002, he has particular expertise in peripheral arterial disease, abdominal aortic aneurysms, kidney transplantation, and congenital vascular malformations. Dr. Koelemay is internationally recognized for his contributions to evidence-based vascular care, non-invasive vascular diagnostics, and clinical research. As a prolific researcher and educator, he has authored numerous influential publications and remains actively involved in advancing vascular surgery through research, guideline development, and patient-centred decision-making.

Dries DORPMANS | Pedal Acceleration Time in CLTI: Can we predict wound healing?

Dr. Dries Dorpmans is a vascular surgeon at AZ Sint-Maarten, Mechelen. After completing his surgical residency training at Máxima MC (Veldhoven), UZ Leuven, Maastricht UMC+, and Ziekenhuis Oost-Limburg (Genk), he worked as a Vascular Surgery Fellow at UZ Leuven until the summer of 2026, after which he joined AZ Sint-Maarten as a staff vascular surgeon. Dr. Dorpmans has a particular interest in peripheral arterial disease and vascular ultrasound, with a special focus on the Pedal Acceleration Time (PAT) technique, on which he has conducted scientific research. He is also actively involved in education and innovation within vascular surgery.

Innovation in below-the-knee revascularisation: Future perspectives?

Houthoofd

Sabrina HOUTHOOFD | Photodynamic therapy in CLTI: From concept to clinical translation

Dr. Sabrina Houthoofd is a vascular and endovascular surgeon at UZ Leuven, where she has been a staff member of the Department of Vascular Surgery since 2007. Following dedicated endovascular training at the Heart Center Leipzig, she developed extensive expertise in minimally invasive vascular interventions, including EVAR, TEVAR, and fenestrated and branched endovascular aneurysm repair. Dr. Houthoofd has a particular interest in peripheral arterial disease and diabetic foot care and serves as coordinator of the diabetic foot clinic. Alongside her clinical work, she is actively involved in research focusing on vascular disease, critical limb ischaemia, and innovative endovascular therapies.
ozan yazar

Ozan YAZAR | Intravascular imaging in BTK disease: OCT and beyond

Dr. Ozan Yazar (MD, PhD) is a vascular and endovascular surgeon at Zuyderland Medical Centre in the Netherlands. After completing his medical training at KU Leuven, he underwent extensive surgical and vascular training in Belgium and Germany, including fellowships at UZ Leuven, Ziekenhuis Oost-Limburg, and the renowned Klinikum Nürnberg Süd under Prof. Eric Verhoeven. Dr. Yazar has a special interest in complex aortic pathology and advanced endovascular techniques and holds a PhD focused on the endovascular treatment of complex abdominal aortic aneurysms. He is an active researcher, author of numerous scientific publications, and a frequent contributor to vascular education and quality improvement initiatives.
Untitled design - 1

Raman UBEROI | Next generation technologies for BTK revascularisation: Drug-coated devices, bioabsorbable scaffolds and AI 

Prof. Dr. Raman Uberoi is a Consultant Interventional Radiologist at the John Radcliffe Hospital, Oxford, and Honorary Senior Lecturer at the University of Oxford. Internationally recognized for his expertise in vascular interventions and aortic stent grafting, he has authored more than 190 peer-reviewed publications, held numerous leadership positions in British and European radiology societies, and was awarded the prestigious CIRSE Gold Medal in recognition of his outstanding contributions to interventional radiology, education, and clinical innovation.
daniel van den heuvel

Daniel VAN DEN HEUVEL | Transcatheter deep venous arterialization in (no-option) CLTI: Hype or future standard?

Dr. Daniel A.F. van den Heuvel is an Interventional Radiologist at St. Antonius Hospital, Nieuwegein (the Netherlands), with a special expertise in peripheral arterial disease and advanced endovascular therapies. After obtaining his medical degree from the University of Amsterdam, he completed his radiology training and fellowship in interventional radiology at St. Antonius Hospital, where he has been a consultant since 2011. Dr. van den Heuvel is internationally recognized for his work in the treatment of chronic limb-threatening ischaemia (CLTI), particularly deep venous arterialization (DVA) for no-option patients. He is actively involved in education, research, and international training initiatives, and is a frequent speaker at major vascular meetings.
Scroll to Top